Selective expansion of high-affinity antigen-specific B cells in germinal centers (GCs) is a key event in antibody affinity maturation. GC B cells with improved affinity can either continue affinity-driven selection or exit the GC to differentiate into plasma cells (PCs) or memory B cells. Here we found that deleting E3 ubiquitin ligases Cbl and Cbl-b (Cbls) in GC B cells resulted in the early exit of high-affinity antigen-specific B cells from the GC reaction and thus impaired clonal expansion. Cbls were highly expressed in GC light zone (LZ) B cells, where they promoted the ubiquitination and degradation of Irf4, a transcription factor facilitating PC fate choice. Strong CD40 and BCR stimulation triggered the Cbl degradation, resulting in increased Irf4 expression and exit from GC affinity selection. Thus, a regulatory cascade that is centered on the Cbl ubiquitin ligases ensures affinity-driven clonal expansion by connecting BCR affinity signals with differentiation programs.
INTRODUCTION
Production of high-affinity antibodies is central to T-cell-dependent humoral immunity against pathogens and occurs in germinal centers (GCs) through a process termed antibody affinity maturation (Liu et al., 1989; Rajewsky, 1996) . Upon encounter with antigen, activated B cells enter GCs to undergo clonal expansion and somatically mutate their B cell antigen receptor (BCR) genes via activation-induced cytidine deaminase (AID)-mediated somatic hypermutation (SHM) in the anatomically distinct dark zone (DZ) (Allen et al., 2007; Berek et al., 1991; Jacob et al., 1991; Muramatsu et al., 2000; Victora and Nussenzweig, 2012) . B cells with a mutant BCR then migrate to the light zone (LZ) to compete for the antigen presented by follicular dendritic cells (FDCs) and for help from T follicular helper (Tfh) cells (Allen et al., 2007; Crotty, 2011; Ramiscal and Vinuesa, 2013; Shulman et al., 2014; Victora and Nussenzweig, 2012) . Higheraffinity BCRs have advantages in this competition for the antigen, allowing B cells to receive more help such as CD40L stimulation from Tfh cells Meyer-Hermann et al., 2012; Schwickert et al., 2007; Victora and Nussenzweig, 2012) . Surviving GC B cells with improved affinity to the antigen might terminate the GC B cell fate and differentiate into memory B cells or plasma cells (PCs), or they might migrate back to the DZ for a further round of SHM and clonal expansion (Bannard and Cyster, 2017; De Silva and Klein, 2015; Dufaud et al., 2017; Mesin et al., 2016; Shlomchik and Weisel, 2012; Victora and Nussenzweig, 2012) . The spatial and temporal circulation between the GC DZ and LZ enables the preferential expansion of B cells with higher-affinity BCRs and allows them to be selected to enter the memory or PC pool.
Given the critical role of such a GC inter-zonal circulation in the generation and selection of high-affinity BCR-expressing B cells, researchers have invested much effort in understanding the mechanisms by which B cells are instructed to stay in or exit the DZ-LZ cycle to become memory B cells or PCs. At the transcriptional level, maintenance of the GC B cell fate is controlled by GC B-cell-promoting transcription factors such as Bcl6 (Basso and Dalla-Favera, 2012) . In contrast, the identity of PCs depends on the transcription factors Blimp1 and Irf4 (Klein et al., 2006; Sciammas et al., 2006; Shapiro-Shelef et al., 2003) . These two groups of transcription factors antagonistically regulate each other and dictate the steady-state distinctive characteristics of GC B cells and PCs, respectively Shapiro-Shelef and Calame, 2005) . In addition to these transcription factors, Myc, Foxo1, and NFkB have been reported to provide additional layers of regulation during the GC reaction (Calado et al., 2012; De Silva and Klein, 2015; Dominguez-Sola et al., 2015; Dominguez-Sola et al., 2012; Heise et al., 2014; Inoue et al., 2017; Sander et al., 2015) . Inactivation of NFkB or Myc in GC B cells results in the collapse of the GCs because of the impaired cycling of LZ B cells to the DZ. Foxo1 is essential for the DZ phenotype; mice with deletion of foxo1 in GC B cells have only LZ cells. However, the molecular mechanisms that sense BCR affinity cues in GC B cells and instruct B cells to continue the DZ and LZ cycle or to initiate the differentiation program to PCs are not fully defined.
Cbl and Cbl-b (Cbls) are members of the Cbl family of E3 ubiquitin ligases expressed in hematopoietic cells (Huang and Gu, 2008) . In B cells, they play a crucial role in the induction of immune tolerance, possibly by regulating the negative selection of autoreactive B cells (Kitaura et al., 2007) . Inactivation of Cbls by use of the Cd19-cre allele results in a moderate increase in IgM and reduction in IgG isotypes of T-cell-dependent antibody responses (Kitaura et al., 2007) . Here, we examined the function of Cbls in the GC reaction. We found that CBLs are essential for the selection of high-affinity GC B cells and antibody affinity maturation. In GCs, the expression of Cbl proteins is minimal in DZ B cells and significantly increased in LZ B cells. They suppress Irf4 expression by promoting Irf4 ubiquitination. Ablation of Cbls in GC B cells increases the expression of Irf4, leading to impaired clonal expansion of high-affinity B cells and expedited GC differentiation, despite normal SHM and DZ-LZ cycling of GC B cells. Consistent with this result, ectopic expression of Irf4 alone or inactivation of the ubiquitin ligase activity of Cbls is sufficient to recapitulate the GC phenotypes found in Cblmutant mice. Thus, the Cbl-Irf4 axis controls the permanence of GC B cells in the DZ-LZ cycle until the acquisition of a highaffinity BCR signals GC exit.
RESULTS

Expression Patterns of Cbls in B Cell Subsets and the GC Reaction
To evaluate whether Cbl proteins regulate the T-cell-dependent antibody response, we first examined the expression patterns of Cbl and Cbl-b in naive and GC B cells. We found decreased amounts of both Cbl and Cbl-b mRNA in GC B cells as compared to naive B cells; however, GC B cells expressed higher amounts of Cbl and Cbl-b proteins in comparison to naive B cells (Figures 1A and 1B and Figure S1A ). The marked alteration seemed to be a GC phenomenon: activation of B cells with anti-IgM or anti-CD40 induced only a mild increase or a decrease in both Cbl and Cbl-b proteins, respectively ( Figure S1B ). Within GC B cell populations, the LZ GC B cells possessed significantly more Cbl and Cbl-b proteins, but not more mRNAs, than the DZ B cells (Figures 1C and 1D and Figures S1C and S1D) . These results indicate that Cbl proteins are post-transcriptionally and dynamically modulated during the GC reaction.
Ablation of Cbl Proteins in GC B Cells Impairs Antibody Affinity Maturation
We then generated Cbl
in which the IgCg-cre allele drove Cre recombinase expression in GC B cells so that only GC B cells (perhaps some activated B cells) carried the Cbl and Cbl-b double-null (termed here as Cbl À/À Cbl-b À/À ) mutation, whereas other cells of the mice harbored the germline cbl-b mutation Chiang et al., 2000; Naramura et al., 2002) . Ablation of Cbl and Cbl-b proteins in GC B cells was confirmed by immunoblot analysis and immunofluorescent staining ( Figures S2A and S2B ). Inspection of Cbl À/À Cbl-b À/À mice revealed normal development of B cells ( Figures S2C and S2D ). Compared to WT mice, the mutant mice produced similar amounts of total anti-4-hydroxy-3-nitrophenyl (anti-NP) (NP 30 ) antibodies of IgM and IgG1 isotypes initially, after immunization with (4-hydroxy-3-nitrophenyl) acetyl-keyhole limpet hemocyanin (NP-KLH); however, they displayed a significantly lower amount of IgG1 at day 28 ( Figure 2A ). In addition to the total antibody titer, Cbl À/À Cbl-b À/À mice exhibited impaired antibody affinity maturation; the amount of anti-NP 4 as well as the ratio of high-affinity anti-NP (NP 4 ) to total anti-NP (NP 30 ) IgG1 was severely impaired in the mutant mice compared to the WT controls ( Figures 2B and 2C ). In the spleen, the mutant mice possessed slightly more IgM antibodysecreting cells (ASCs) against NP 30 antigen. In contrast, they had markedly reduced numbers of total (anti-NP 30 ) as well as high-affinity (anti-NP 4 ) IgG1 ASCs in comparison to their WT counterparts ( Figure 2D ). The discrepancy between the serum anti-NP 30 antibody titers at day 14 ( Figure 2A ) and the numbers of anti-NP 30 ASCs at day 12 ( Figure 2D ) could be explained by the fact that the former reflects the accumulative antibodies produced by BM and peripheral ASCs, whereas the latter included only the splenic ASCs present at the given date. In T-cell-dependent immune responses, ASCs or PCs are mostly derived from GC B cells. To examine whether the Cbl 
Data are means ± SEM (A-G) and are representative of two or three independent experiments with at least four mice per group. *p < 0.05; **p < 0.001; ***p < 0.0001 (unpaired Student's t test).
Cbl-b
À/À mutation affected the GC reaction, we analyzed the kinetics of GC B cell development during the course of immunization. At day 8 after immunization, WT and Cbl À/À Cbl-b À/À mice developed equal percentages of GC B cells; however, whereas WT mice exhibited a peak GC development at day 11 and declined GC B cell numbers thereafter, the mutant mice had a slow increase in GC B cells up to day 22 ( Figure 2E ). The altered kinetics of GC B cell development in the mutant mice could be partly attributed to a combinatory effect of expedited differentiation and reduced apoptosis because Cbl
GC B cells generated more PCs (see below) and a lower number of active Caspase-positive cells than did the WT controls (Figure 2F) . Cell-cycle analysis revealed similar proportions of G1, S, and G2/M phase cells, indicating that the proliferation of GC B cells was not affected by the Cbl À/À Cbl-b À/À mutation ( Figure S2E ). In addition to the altered kinetics of GC B cell expansion, the mutant mice had a lower number of GC B cells expressing a high-affinity cell-surface IgG1 BCR against NP antigen than did the WT mice throughout the course of immunization ( Figure 2G ). Cbl-b À/À B cells exhibited an R/S ratio equivalent to that expected for the random mutation (R/S = 2.2) ( Figure 3D ). Figure S3B and S3C).
To directly examine whether Cbls regulated cellular selection of high-affinity BCR-expressing cells inside GCs, we compared the kinetics of high-affinity NP (NIP 5 ) and total NP (NP 38 )-binding GC B cell development at different time points upon NP-KLH immunization ( Figure 3E ). At day 8 after immunization, WT mice had approximately 20% NIP 5 -binding and 31% NP 38 -binding GC B cells, indicating that approximately 65% of total NP-specific GC B cells express a high-affinity BCR as defined by NIP 5 -binding capability. By day 14, the ratio of NIP 5 -to NP 38 -binding GC B cells increased to more than 90%, indicating that the high-affinity NP-specific B cell population is selectively expanded within total NP-specific GC B cells. In contrast to WT mice, Cbl À/À Cbl-b À/À mice possessed relatively lower numbers of NIP 5 -and NP 38 -binding GC B cells at day 8 (average 5% and 9%, respectively), equivalent to approximately 61% of NIP 5 -binding cells among total NP 38 -binding cells. By day 14, this ratio only increased slightly, to less than 70%, indicating that the selection for NIP 5 -binding cells is severely impaired in the mutant mice. Taken together, the above data demonstrate that Cbls are required for the selection of high-affinity BCR-expressing B cells during the GC reaction. However, they appear to be dispensable for the regulation of SHM in GC B cells.
The Cbl -/-Cbl-b -/-Mutation Expedites GC B Cell Differentiation to PCs During affinity maturation, GC B cells undergo multiple cycles of proliferation and SHM in the DZ and selection and differentiation to PCs and memory B cells in the LZ (Meyer-Hermann et al., 2012; Victora et al., 2010) . Disruption of these cycles can impair affinity-driven selection of GC B cells (Allen et al., 2007; Mesin et al., 2016) . To understand the mechanisms by which Cbl proteins regulate GC affinity selection, we examined whether the Cbl We then performed a BrdU labeling experiment to determine whether GC B cell development into PCs was increased in the mutant mice. At day 12 after immunization, in both WT and Cbl-b À/À mice produced only 1%-2% of the BrdU + PCs (Figure S5B) . Given that the mutant mice had fewer GC B cells than WT controls at day 12 after immunization ( Figure 2E ), the increased PC genesis in Cbl
with the idea that Cbl proteins are responsible for retaining GC B cells in the DZ-LZ cycle and preventing them from differentiation into PCs.
To directly assess the effect of Cbls on the fate choice of B cells in developing GCs in the context of affinity selection, we examined the development of high-affinity NP-specific GC B cells and PCs upon inducible ablation of Cbls. We transferred B cells from ER-Cre tg (control) or
) mice into mMT recipient mice and immunized the chimeric mice with NP-KLH so that the donor B cells could enter and initiate GC reaction. We then deleted Cbl by tamoxifen at day 7 after immunization, at which stage about 60% of NP-specific B cells had already acquired a high-affinity BCR ( Figure 3E ), and we analyzed NIP 5 -binding GC B cells and PCs at day 12 by flow cytometry. Cbl-ablated mice showed a marked reduction in the number of NIP 5 -binding GC B cells; however, the total number of GC B cells was only reduced to a half of that in controls ( Figure 4C ). Consistently, Cbl ablation led to significant increases in the numbers of total and NIP 5 -binding PCs relative to mice without Cbl deletion ( Figure S5C and S5D). Given that high-affinity PCs are mostly generated through the GC reaction, a concomitant reduction in NIP 5 -binding GC B cells and increase in NIP 5 -binding PCs supports the idea that a loss of Cbls helps the high-affinity GC B cells to choose the PC fate and differentiate into PCs.
Differentiation of GC B cells to PCs is influenced by CD40 and the BCR (Kr€ autler et al., 2017) . To determine whether Cbls control the PC differentiation program via these signaling pathways, we compared CD40-and BCR-induced B cell differentiation to PCs in vitro. Figure S5E ). These cells appeared to be PCs or plasma blast-like cells because they expressed intracellular Ig, upregulated Irf4, and downregulated Bcl6 ( Figure S5F ). Similarly, a culture of freshly isolated Cbl À/À Cbl-b À/À GC B cells on CD40LB feeders also generated more B220 + CD138 + plasma blast-like cells than did WT controls ( Figure 4E ). In contrast, anti-IgM stimulation alone produced comparable numbers of B220 + CD138 + cells from the mutant and WT B cells, suggesting that BCR-signaling-induced PCs are not enhanced by the Cbl Figure S5E ). Neither CD40-nor BCR-induced proliferation of B cells was affected by the Cbl Figure S5G ). Together, these data indicate that ablation of Cbl proteins does not affect CD40-or BCR-induced mitotic signaling but rather expedites CD40-induced B cell differentiation into PCs.
The frequency of B cell differentiation into PCs increases with each cycle of cell division (Hasbold et al., 2004) . To study the influence of the Cbl The Cbl -/-Cbl-b -/-Mutation Enhances the Expression of Irf4 but Not mRNA in GC B Cells The identities of GC B cells and PCs are respectively controlled by Bcl6 and Blimp1. Irf4 provides another layer of regulation by repressing Bcl6 and promoting Blimp1 gene transcription . To elucidate how the Cbl À/À Cbl-b À/À mutation affected the GC B cell differentiation program, we compared the gene expression profiles of GC B cell and PC identity genes in WT and Cbl À/À Cbl-b À/À GC B cells at day 12 after immunization.
RNA-seq analysis revealed that the expression of $900 genes was decreased and that of $50 genes increased at least 2-fold in Cbl À/À Cbl-b À/À GC B cells as compared to WT controls ( Figure S6A) ; however, this analysis revealed slightly lower expression of several known GC B cell or PC identity genes, such as Bcl6, Bach2, Irf4, and Aicda ( Figure S6B ). qPCR analysis confirmed that while the expression of Bcl6, Bach2, and Aicda was slightly reduced, the expression of PC identity gene Irf4 was not increased in the mutants compared to WT GC B cells ( Figure 5A ). Despite this observation, the mutant GC B cells elevated the expression of multiple genes related to RNA processing and protein translation and secretion involved in PC function ( Figure 5B and Figure S6A ), suggesting that some mutant B cells already initiate the PC differentiation program.
To determine whether the Cbl À/À Cbl-b À/À mutation influenced the PC development program at the protein level, we examined CD40 and BCR signaling, as well as the amounts of Bcl6 and Irf4 proteins in GC B cells. We found that activation of CD40 or BCR signaling pathways, including canonical NF-kB, AKT, S6K, and ERK pathways, was not altered by the Figures S6C-S6E ). In contrast, the expression of Irf4 protein was markedly increased in freshly isolated mutant GC B cells compared to the controls ( Figure 5C ). Figure 5D ).
Stimulation of CD40 and BCR for 3 hr significantly increased Figure 5F ). This result, along with the mRNA expression data, indicates that Cbl proteins do not affect the major signaling pathways downstream of CD40 or the BCR. Instead, they might retain a GC B cell fate by suppressing the expression of Irf4 rather than Irf4 transcription.
Cbls Promote Nuclear Irf4 Ubiquitination and Degradation
Cbl proteins are known cytosolic E3 ubiquitin ligases, whereas Irf4 is a transcription factor that functions mainly in the nucleus.
We therefore examined at which subcellular location Cbl proteins exert their regulatory function on Irf4. Confocal microscopy analysis showed that Irf4 was barely detectable in freshly isolated WT GC B (B220 + GL7 hi Fas hi ) cells and significantly accumulated in the nucleus after CD40 and BCR stimulation. In contrast, a significant proportion of Cbl
already possessed a high amount of nuclear Irf4 in the absence of any stimulation ( Figures 6A and 6B ). In agreement with this observation, immunoblot analysis confirmed that Irf4 was expressed in both cytosol and nucleus, and the mutant GC B cells expressed several-fold more Irf4 in the nucleus than did WT cells even in the absence of any stimulation ( Figure 6C ). As for Cbls, in freshly isolated WT GC B cells both Cbl and Cbl-b were expressed in the cytosol and nucleus in the absence of CD40 stimulation; Cbl was expressed more strongly in cytosol and Cbl-b more strongly in the nucleus ( Figure 6D ). CD40 and BCR stimulation for 1 hr significantly diminished Cbl-b, and stimulation for 3 hr reduced both Cbl-b and Cbl in the nucleus. The stimulation concomitantly increased the amount of nuclear Irf4 ( Figure 6D ), suggesting that nuclear Cbl proteins eradicate Irf4 in GC B cells.
To determine whether Cbl proteins regulated Irf4 expression by promoting Irf4 ubiquitination, we co-expressed Irf4 with Figures  6G and 6H) . Thus, the observed dynamic change of Irf4 expression in GC LZ B cells is at least partly regulated by Cbl-dependent Irf4 ubiquitination and degradation.
Lack of Cbl Ubiquitin Ligase Activity or Increase in Irf4
Expression Is Sufficient to Impair GC Affinity Selection The above results suggest a hypothesis that the elevated amount of Cbls in GC B cells removes Irf4 by promoting Irf4 ubiquitination and consequently allow continuation of the GC cycle until high-affinity BCRs are acquired. If this is the case, we expected that inactivation of Cbl ubiquitin ligase activity or increased Irf4 expression in GC B cells impairs antibody affinity maturation. To examine whether Cbl ubiquitin ligase activity was required for antibody affinity maturation, we bred Cbl fl/fl mice to IgCg-Cre tg and Cbl-b C373A/C373A mice; the latter expressed a mutant Cbl-b whose ubiquitin ligase activity was inactivated by a cysteine-to-alanine mutation at position 373 (Oksvold et al., 2008) . The resulting
) mice were immunized with NP-KLH. The development of high-affinity GC B cells and PCs was examined by flow cytometry and ELISPOT, respectively. Cbl Figure 7A and Figure S7A ). In addition, the numbers of high-affinity anti-NP (NP 8 ) GC B cells as well as anti-NP 8 IgG1-secreting PCs were all reduced in the mutant mice relative to the controls ( Figures 7B and 7C and Figure S7A ). To determine whether increased Irf4 was sufficient to abolish antibody affinity maturation, we ectopically expressed Irf4 in WT hematopoietic stem cells by a retroviral vector and generated BM chimeras (termed Irf4-MSCV BM mice). Expression of the transgenic Irf4 was confirmed by immunoblot analysis (Figure S7B) . These mice were then immunized with NP-KLH, and selection of high-affinity NP-binding GC B cells and PCs was analyzed by flow cytometry. Similar to that found in Cbl
meras the transgene Irf4-expressing (Irf4-MSCV) B cells generated a slightly lower number of GC B cells at day 12 than did B cells infected with empty retrovirus (MIGR-MSCV) ( Figure 7D ), indicating that Irf4-overexpressing B cells can enter the GC reaction. However, the production of high-affinity anti-NP 8 IgG1-expressing GC B cells was impaired in the mutant (Irf4-MSCV, GFP + ) but not in WT controls (MIGR-MSCV, GFP + ) ( Figure 7E ).
The numbers of PCs generated from Irf4-MSCV-infected B cells were consistently increased as compared to cells infected with empty vector ( Figure 7F ). Together, these results indicate that lack of ubiquitin ligase activity of Cbls or excessive Irf4 expression is sufficient to abolish the development of high-affinity GC B cells.
DISCUSSION
Selective expansion of high-affinity BCR-expressing B cells in
GCs is a critical step in antibody affinity maturation. We found that Cbls play an indispensable role in this regulation: ablation of Cbls in GC B cells selectively impaired the development of GC B cells expressing high-but not low-affinity BCRs. Loss of Cbls in GC B cells did not significantly alter the efficiency of SHM per se but rather impeded the clonal expansion of high-affinity B cells in GCs. Because inactivation of Cbl ubiquitin ligase activity was sufficient to recapitulate this GC phenotype, our studies support the notion that Cbls define a ubiquitinationdependent regulatory pathway that enforces affinity-driven clonal selection of high-affinity GC B cells.
It is generally envisioned that high-affinity BCRs facilitate clonal expansion and selection of GC B cells via two modes of regulation. First, high-affinity BCRs might drive more vigorous cell proliferation because they elicit stronger BCR signaling than low-affinity BCRs. However, this proposition has received conflicting evidence; attenuated rather than enhanced BCR signaling is favorable for GC B cell expansion, and high-affinity BCRs tend to cease GC B cell fate and initiate PC differentiation (Khalil et al., 2012; Kr€ autler et al., 2017) . As an alternative to the signaling role of the BCR in GC affinity selection, high-affinity BCRs are thought to capture more antigen than BCRs with inferior affinity, thus giving high-affinity B cells the advantage of competing for the help of Tfh cells, mainly via the increased expression of CD40L Liu et al., 2015) . A challenging question is how B cells interpret BCR affinity cues differently given that the same BCR and CD40 signals control both the mitotic and differentiation pathways of GC B cells. In our studies, we found that ablation of Cbls expedited GC B cell differentiation but not proliferation upon CD40 and/or BCR stimulation. This finding thus places Cbls in the signaling pathway at a point where they prevent B cell differentiation rather than affecting proliferation.
In line with this view, we observed that the Cbl À/À Cbl-b À/À mutation did not affect CD40-or BCR-induced mitotic signaling pathways, such as those mediated by AKT, S6K, ERKs, and canonical NF-kB. Instead, it resulted in the accumulation of Irf4 in GC B cells. We also found that Cbls promote Irf4 ubiquitination in B cells. CD40 and BCR stimulation decreased the expression of Cbls and, conversely, increased the expression of Irf4 in GC B cells. Finally, ablation of Cbls in GC B cells via an ER-Cre inducible system preferentially helped high-affinity B cells to terminate the GC fate and differentiate into PCs. These findings together offer a model wherein by clearing Irf4 protein rather than regulating the mitotic signaling pathways, Cbls enable CD40 and BCR signals to promote GC B cell proliferation without activating the PC differentiation program. This regulation can be reversed in high-affinity GC B cells, in which strong CD40 and BCR signaling generated by the high-affinity BCR cue decreases the expression of Cbls and leads to increased amounts of Irf4 and differentiation of these cells into PCs. The fates of GC B cells and PCs are determined by transcription factors Bcl6, Irf4, and BLIMP Shapiro-Shelef and Calame, 2005) . However, a recent transcriptome study revealed that transcription of Bcl6 is abruptly decreased, whereas that of Irf4 and pmdr1 is abruptly increased in plasmablasts, hence raising a question as to what is the initial ''push'' that drives the transition of this transcriptional network from the equilibrium state of GC B cells to that of PCs (Shi et al., 2015) . Our data reveal that in WT mice a small population of GC B cells downregulated Bcl6 and upregulated Irf4 (Bcl6   lo   Irf4 hi ). Triggering of CD40 and BCR for a short period increased this cell subset, suggesting that these cells represent emerging plasmablasts or plasma-cell precursors. Development of this subset appeared to be controlled by Cbls because they were significantly increased in the GCs of Cbl
mice. In GC B cells, we showed that Cbls ubiquitinated Irf4. Strong CD40 and BCR stimulation decreased the expression of Cbl proteins and concomitantly increased the expression of Irf4. We therefore propose that relief of Irf4 from Cbl-mediated ubiquitination upon strong CD40 and/or BCR triggering is the earliest PC fate commitment event occurring in the LZ GC B cells; it precedes the conversion of transcriptomes from the state of GC B cells to that of PCs. This of course will not refute the role of CD40 in promoting Irf4 transcription, which might be compromised in LZ B cells at the Irf4 protein level until Cbls are degraded. Previous studies have shown that selection of high-affinity GC B cells depends on the transcription factors NFkB, Myc, and Foxo1, in a B cell-intrinsic fashion. Both Myc and canonic NFkB are expressed or activated in a small subset of LZ GC B cells (Calado et al., 2012; De Silva and Klein, 2015; Dominguez-Sola et al., 2015; Heise et al., 2014) . Ablation of Myc, rel, or relb, respectively, in GC B cells results in the collapse of the GC reaction because these factors are required for maintaining the GC reaction by facilitating LZ-to-DZ circulation. Foxo1 is required for sustaining the DZ program, as evidenced by the fact that inactivation of Foxo1 disrupts the expansion of DZ B cells, possibly by dysregulating the function of the transcription factor Batf (Inoue et al., 2017) . In contrast to the above regulations, Cbls control GC affinity maturation by determining the time at which a GC B cell is allowed to enter the PC pool. In this regard, Cbls seem to represent a new regulation that controls the exit checkpoint of the DZ-LZ cycle and consequently contributes to BCR affinity selection. It will be interesting to determine whether this mechanism also contributes to the recently described temporal switch in the differential output of memory B cells and PCs during the GC reaction (Weisel et al., 2016) .
Selection of high-affinity B cells occurs in the GC LZ, where BCR affinity cues can be assessed via interaction with antigen presented on follicular dendritic cells (Heesters et al., 2014) . Our findings that the expression of Cbls is markedly increased in GC LZ compared to DZ B cells at the protein but not at the mRNA level, and that CD40 and BCR signals reduce the expression of Cbl proteins, raise an interesting question as to how the expression of Cbls is spatially and temporally controlled during the GC DZ-LZ cycle. CD40 is known to activate RING-domaincontaining Trafs or cIAPs, both of which regulate their respective downstream signaling molecules by ubiquitination (Elgueta et al., 2009) . Along this line, at least Traf 6 and Traf 2 have been shown to associate with Cbl-b (Elgueta et al., 2009) . Alternatively, CD40 signal could modulate the translation of Cbl proteins through a microRNA-dependent mechanism. Consistent with this speculation, it has been found that CD40 stimulation enhances the expression of multiple microRNAs, among which miR155 might influence Cbl-b expression in B cells (Loeb et al., 2012; Vigorito et al., 2007) . Nevertheless, it will be worthwhile to investigate whether modulation of the Cbl pathway can be used as a strategy to improve clinical benefits, such as the efficiency of vaccination.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice C57BL/6 mice, B6.SJL mice, mMT mice, Rag1 À/À and UBC-Cre-ERT2 mice were from The Jackson Laboratory. Cbl floxed and
Cbl-b À/À mice were described previously (Chiang et al., 2000; Naramura et al., 2002) . To generate Cbl À/À Cbl-b À/À mice, Cbl floxed/floxed (Cbl fl/fl ) and Cbl-b À/À mice were crossed to IgCg1-Cre transgenic mice kindly provided by S. Casola and K. Rajewsky . Cbl-b C373A mice were described previously (Oksvold et al., 2008 were purified by FACS sorting. Purified B cells were seeded onto irradiated (900 RAD) 40LB cells described previously (Nojima et al., 2011) . B cells were cultured at 37 C for five days, trypsinized and replated onto a fresh 40LB plate for two more days before being subjected to FACS analysis.
Immunization and GC B Cell Purification
To test T-dependent antibody responses and germinal center reaction, 6 to 10 week-old mice were immunized with either 10 9 sheep red blood cells (SRBCs) (Innovative Research) in PBS or NP 36 -KLH (BioSources) precipitated in alum adjuvant (Imject Alum, ThemoScientific) by i.p. injection. Mice were analyzed at different days after immunization. To examine the expression of Cbls in GC B cells, SRBC immunized mice were sacrificed at day 8 and B cells were enriched by a magnetic column, stained with anti-B220, CD138, GL7, Fas, CXCR4 and CD86. GC (B220 + GL7 hi Fas hi ) B cells were then purified by FACS sorting on a FACS Aria or Moflo. To obtain a large quantity of GC B cells for in vitro stimulation and culture, mice were sequentially immunized at day 0 (1x10 8 SRBCs) and day 5 (1x10 9 SRBCs) by i.v. injection. Immunized mice were sacrificed at day 12, B cells were enriched by a magnetic B cell enrichment column (StemCell) and subsequently sorted as B220 + CD138 -GL7 + cells. Purity of the isolated GC B cells was confirmed by FACS analysis and was shown to be more than 95% pure for cell surface markers B220 + GL7 hi Fas hi ( Figure S7C ).
Flow-Cytometric Analysis
Total splenic cells or splenic B cells were resuspended in FACS buffer (5%BSA in PBS (PH = 7.2)) and stained with the corresponding antibodies on ice for 30 min. Cells were washed twice with FACS buffer and then subjected to analysis on a BD Fortessa or Cyan or to cell sorting on a FACS Aria or Moflo. The following antibodies were used for the staining: anti-B220, anti-GL7, anti-CD11c, antiCD11b, anti-Gr1, anti-F4/80, anti-NK1.1, anti-Irf4, anti-Igl, anti-TCRb, anti-CD3ε, anti-CD86, and anti-CD38 (eBioscience); antiFas, anti-CD138, anti-Bcl6, anti-CXCR4, anti-IgG1, anti-IgD (BD PharMingen). High affinity and total NP-binding B cells and plasma cells were stained with NP 8 -PE, NIP 5 APC, and NP 38 -PE (BioSearch), respectively. Specificity of NIP 5 -APC and NP 38 -PE to NP-specific but not to carrier protein specific BCRs was confirmed using GC B cells from OVA or NP 16 -OVA immunized mice ( Figure S7D ). To analyze nuclear proteins Bcl6 and Irf4, total splenic cells were first stained for B220, Fas, and GL7, fixed and permeabilized with Foxp3 staining buffer according to the manufacturer's instructions (eBioscience), and then stained with anti-Bcl6 and Irf4. For cell cycle analysis, mice were injected intravenously with 1 mg of BrdU (BD PharMingen) in DPBS. Cells were then surface stained with corresponding antibodies, and BrdU labeled cells were stained using an anti-BrdU kit according to the manufacturer's protocols (BD PharMingen). mice were purified by FACS sorting. Total RNAs from sorted cells (pooled from three mice) was extracted using an RNEasy Mini Kit (QIAGEN), and reversely transcribed into cDNA using a Reverse-Transcription kit (Invitrogen) according to manufacturer's instructions, respectively. RNA-seq was performed using the Illumina TruSeq Stranded mRNA Kit according to manufacturer's instructions on an Illumina HiSeq 2000 sequencer. Read quality was confirmed using FastQC v0.10.1. Read alignment was performed using TopHat v2.0.10 on the mouse GRCm38/mm10 genome. Differential expression analysis was performed with DESeq2 from the raw alignment counts calculated with featureCounts. Differentially expressed genes were defined as genes with a jlogFC(counts)j>2 and counts > 500 in both experiments. Shown are log2 ( Immunofluorescence Spleens were embedded in optimum cutting temperature compound (Sakura) and flash-frozen in liquid nitrogen. Tissue sections were cut on Cryotome (Leica), fixed in ice-cold acetone (Sigma), blocked with PBS+5%BSA for 1 hour at 25 C, and stained with anti-Cbl (Santa Cruz), anti-Cbl-b (Santa Cruz), anti-CD35 (BD PharMingen), anti-B220 (BD PharMingen), and/or PNA (VectorLab), in different combination. The following secondary antibodies were used to detect primary antibodies: anti-Rabbit Alexa-568 (Invitrogen), Streptavidin Alexa 488 (Invitrogen), Streptavidin Alex-633 (Invitrogen). Images were acquired on a Zeiss LSM700 or 710 confocal microscope.
For intracellular staining of Irf4, GC B cell or stimulated GC B cells were purified by FACS sorting. Cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100, blocked with PBS+5% BSA, and stained with anti-Irf4 (Santa Cruz), followed by anti-Goat Alexa 568 secondary antibody. Cell nucleus was counter stained with DAPI. Images were acquired on a Zeiss LSM710 confocal microscope. (Dominguez-Sola et al., 2012) . PCR products were gel extracted and cloned into a TOPO vector (Invitrogen). High quality traces were analyzed using MacVector for base pair mismatches and deletions as compared to the germline V H 186.2 gene sequence. Only mismatches mutations in the productive V H 186.2-J H 2 joints were counted as mutations. Ig V H sequences were analyzed using the IMGT/V-QUEST system to identify the W33L mutation. Primers used were: V H 186.2: 5 0 -AGCTGTATCATGCTCTTCTTGGCA À3 0 ; J H 2: 5 0 -AGATGGAGGCCAGTG AGGGAC À3 0 .
Enzyme-Linked Immunospot (ELISPOT) Assay and Enzyme-Linked Immunosorbent Assay (ELISA) Total splenic or bone marrow cells were cultured at 37 C in antigen pre-coated 96-well Multiscreen-HA filter plates (Millipore) overnight. Spots of antibody secreting cells were stained with rabbit anti-mouse IgM or IgG1 antibodies conjugated to horseradish peroxidase (Invitrogen), and then developed by addition of AEC substrate (BD PharMingen). Plates were washed extensively and spots were counted on a dissect microscopy. The antigens used for plate coating were NP 4 -OVA and NP 30 -OVA, respectively. Anti-NP ELISAs were performed as described previously (Jang et al., 2011) .
Immunoprecipitation and Immunoblot Analysis
Cells were lysed in TNE buffer (50mM Trise; 140mM NaCl; 5mM EDTA; 0.5% SDS), and immunoblotting was performed following standard procedures. For immunoprecipitation, proteins were immunoprecipitated by incubation of cell lysate overnight at 4 C with the appropriate antibodies (1 mg), followed by precipitate the protein-antibody complexes by incubating with protein G agarose (Invitrogen) for another 1 hour at 4 C. Immunoprecipitates were washed four times with TNE buffer, boiled in 40 mL loading buffer and immunoblotted to a PVDF membrane for western blot analysis. The following antibodies were used for biochemical study: anti-IgM F(ab) 2 (BioSource); anti-CD40 (ENZO); anti-Cbl (SantaCruz); anti-Irf4 (SantaCruz); anti-Lamin B (SantaCruz); anti-BLIMP1 (SantaCruz); anti-HA (SantaCruz); anti-Cbl-b (Cell signaling); anti-b Actin (abcam); anti-Flag (Sigma). Horseradish-peroxidaseconjugated goat anti-rabbit, goat anti-mouse or donkey anti-goat antibody was used as a secondary antibody, respectively. Membranes were developed with an enhanced chemiluminescence detection system (GE Healthcare).
A Nuclear extraction kit was used to fractionate nuclear and cytoplasmic proteins according to manufacturer's instructions (Active motif).
Bone Marrow and Cbl
-/-Cbl-b -/-ERCre B Cell Chimeric Mice
To generated Irf4 overexpression or IkB-GFP expressing bone marrow chimeric mice, retroviral stocks were prepared by transfection of Phoenix cells with MSCV-MIGR1 (empty vector), Irf4-MSCV or MSCV-IkB-GFP retroviral vector together with the packaging vector pCL-Eco by the standard calcium transfection (Han et al., 2010) . Viral supernatants were collected 48 h and 72 h after the transfection, respectively. To obtain bone marrow stem cells, donor mice were treated with 5-FU (5 mg/mouse, i.p.). Four days later, bone marrow stem cells were collected and cultured under optimal stem cell culture condition. After two-rounds retroviral spin-infections, bone marrow cells were adaptively transferred into lethally irradiated (10 Gy) Rag1 À/À recipient mice. Six weeks later, mice were subjected to different immunization regimens.
To generate Cultured B cells were harvested and cell proliferation was analyzed on a FACS. To examine culture B cell differentiation to PCs, cells were stained with B220, CD138, and Irf4. Irf4 and CD138 positive cells in each cell division were analyzed on a FACS.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed with a two-tailed, unpaired Student's t test or Fisher's exact t test, with GraphPad Prism V7 software. A P value < 0.05 was considered statistically significant.
